The FDA rejected use of an ecstasy-based drug along with mental-health therapy in the treatment of post-traumatic stress disorder, asking Lykos Therapeutics to test the drug therapy further.
Wall Street Journal
The FDA rejected use of an ecstasy-based drug along with mental-health therapy in the treatment of post-traumatic stress disorder, asking Lykos Therapeutics to test the drug therapy further.
https://www.wsj.com/health/pharma/fda-rejects-ecstasy-based-drug-cfc4b4b5